| Date Filed | Type | Description |
| 08/25/2023 |
4
| Arnold Jonathan (SVP, CCO & Div. Head BioP Del.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 1,590 shares
@ $0
Sold 87 shares
@ $44.87, valued at
$3.9k
|
|
| 08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
4
| Arnold Jonathan (SVP, CCO & Div. Head BioP Del.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 62 shares
@ $47.8, valued at
$3k
|
|
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Arnold Jonathan (Pres. Oral & Specialty Deliv.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 4,017 shares
@ $0 |
|
| 11/03/2021 |
4
| Arnold Jonathan (Pres. Oral & Specialty Deliv.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 10,672 shares
@ $140.02, valued at
$1.5M
Exercised 1,962 options to buy
@ $36.02, valued at
$70.7k
Exercised 1,039 options to buy
@ $42.23, valued at
$43.9k
Exercised 2,400 options to buy
@ $43.88, valued at
$105.3k
Exercised 2,158 options to buy
@ $54.94, valued at
$118.6k
|
|
| 10/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2020 |
4
| Arnold Jonathan (Pres. Oral & Specialty Deliv.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 9,741 shares
@ $0
Paid exercise price by delivering 2,933 shares
@ $87.71, valued at
$257.3k
Granted 291 shares
@ $0
Paid exercise price by delivering 90 shares
@ $87.71, valued at
$7.9k
|
|
| 08/03/2020 |
4
| Arnold Jonathan (Pres. Oral & Specialty Deliv.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 1,136 shares
@ $0
Granted 6,158 options to buy
@ $88.1, valued at
$542.5k
|
|
| 07/28/2020 |
4
| Arnold Jonathan (Pres. Oral & Specialty Deliv.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Paid exercise price by delivering 3,796 shares
@ $81.64, valued at
$309.9k
|
|
| 04/13/2020 |
4
| Arnold Jonathan (Pres. Oral & Specialty Deliv.) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 264 shares
@ $56.46, valued at
$14.9k
|
|
| 08/26/2019 |
4
| Arnold Jonathan (President, Oral Drug Delivery) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 9,010 shares
@ $0
Paid exercise price by delivering 2,765 shares
@ $55.24, valued at
$152.7k
|
|
| 07/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2019 |
4
| Arnold Jonathan (President, Oral Drug Delivery) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 1,602 shares
@ $0
Granted 8,634 options to buy
@ $54.94, valued at
$474.4k
|
|
| 09/18/2018 |
3/A
| Arnold Jonathan (President, Oral Drug Delivery) has filed a Form 3/A on Catalent, Inc. |
| 09/04/2018 |
4/A
| Arnold Jonathan (President, Oral Drug Delivery) has filed a Form 4 on Catalent, Inc.|
Txns:
| Paid exercise price by delivering 518 shares
@ $43.66, valued at
$22.6k
|
|
| 08/29/2018 |
4
| Arnold Jonathan (President, Oral Drug Delivery) has filed a Form 4 on Catalent, Inc.|
Txns:
| Paid exercise price by delivering 518 shares
@ $43.66, valued at
$22.6k
|
|
| 08/27/2018 |
4
| Arnold Jonathan (President, Oral Drug Delivery) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 3,566 shares
@ $0
Paid exercise price by delivering 1,117 shares
@ $41.83, valued at
$46.7k
|
|
| 07/25/2018 |
4
| Arnold Jonathan (President, Oral Drug Delivery) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 2,006 shares
@ $0
Granted 10,289 options to buy
@ $43.88, valued at
$451.5k
|
|
| 11/06/2017 |
3
| Arnold Jonathan (President, Oral Drug Delivery) has filed a Form 3 on Catalent, Inc. |